Nanoliposomes are a promising delivery system, however, they are quickly broken down under physiological conditions leading to carrier leakage. Hesperetin (HST) is a flavanone with various potential health-related benefits, which are limited by its poor bioavailability and stability. This study aimed to improve the bioavailability of HST using different delivery systems including maltodextrin (MD), β-cyclodextrin (CD), and nanoliposomes coated with two biopolymers, chitosan (CH) and carrageenan (CGN). The capsules underwent in vitro digestion using the INFOGEST protocol and Caco-2 Transwell models were used to simulate intestinal epithelium absorption. Data showed chitosan and carrageenan conjugated-nanoliposomes retained 76 % of the HST at the end of the intestinal digestion, whereas delivery systems such as MD and CD retained only 30% and 66%, respectively. CH and CGN capsules also showed the highest HST transfer rate through the intestinal epithelium, which was a threefold increase compared to free HST after 6 h. Polysaccharide-coated nanoliposomes are an effective tool for delivering bioactive compounds to the small intestine and for improving their transepithelial transport.
No takes yet. Share an insight, caveat, or question.
Meng et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: